Publications by authors named "Roberta Prinapori"

Claim this Profile
I
Innovative Approaches to Monitor Central Line Associated Bloodstream Infections (CLABSIs) Bundle Efficacy in Intensive Care Unit (ICU): Role of Device Standardized Infection Rate (dSIR) and Standardized Utilization Ratio (SUR)-An Italian Experience.
Silvia Boni, Marina Sartini, Filippo Del Puente, Giulia Adriano, Elisabetta Blasi Vacca, Roberta Prinapori

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review.
Giammarco Baiardi, Michela Cameran Caviglia, Fabio Piras, Fabio Sacco, Roberta Prinapori

Antibiotics (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center.
Andrea Parisini, Silvia Boni, Elisabetta Blasi Vacca, Nicoletta Bobbio, Filippo Del Puente, Roberta Prinapori

Antibiotics (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy.
Roberta Prinapori, Barbara Giannini, Niccolò Riccardi, Francesca Bovis, Mauro Giacomini

Epidemiol Infect· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.
Antonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, Gioacchino Angarano, Andrea Gori

J Acquir Immune Defic Syndr· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning HIV-infected children and adolescents into adult care: an Italian real-life experience.
Ambra Righetti, Roberta Prinapori, Loredana Nulvesu, Laura Fornoni, Claudio Viscoli

J Assoc Nurses AIDS Care· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study.
Roberta Gagliardini, Barbara Rossetti, Claudia Bianco, Stefano Rusconi, Manuela Colafigli, Roberta Prinapori

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort.
Antonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, Gioacchino Angarano, Andrea Gori

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of HCV-RNA decay and IP-10 levels after 48 hours of standard HCV therapy as predictors of rapid virological response.
Roberta Prinapori, Laura Sticchi, Cristiano Alicino, Filippo Del Puente, Giovanni Mazzarello

Clin Res Hepatol Gastroenterol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system.
Chiara Dentone, Daniela Fenoglio, Eva Schenone, Giovanni Cenderello, Roberta Prinapori

HIV Clin Trials· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
May some HCV genotype 1 patients still benefit from dual therapy? The role of very early HCV kinetics.
Monica Tontodonati, Valeria Cento, Ennio Polilli, Cecilia Colabattista, Raffaella Cascella, Roberta Prinapori

New Microbiol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
Laura Sticchi, Antonio Di Biagio, Marina Sartini, Emanuela Rappazzo, Laura A Nicolini, Roberta Prinapori

New Microbiol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS.
Roberta Prinapori, Antonio Di Biagio

Patient Prefer Adherence· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease of renal function in HCV and HIV/HCV-infected patients with telaprevir-based therapy.
Roberta Prinapori, Elena Ricci, Barbara Menzaghi, Vanni Borghi, Paolo Maggi

AIDS· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?
Antonio Di Biagio, Roberta Prinapori, Lucia Taramasso, Giulia Gustinetti, Laura Sticchi

Recent Pat Antiinfect Drug Discov· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated histoplasmosis with mucocutaneous immune reconstitution inflammatory syndrome in an HIV-infected patient.
Emanuele Delfino, Antonio Di Biagio, Karthikka Chandrapatham, Claudio Viscoli, Roberta Prinapori

AIDS Res Hum Retroviruses· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV.
Roberta Prinapori, Raffaella Rosso, Antonio Di Biagio, Franca Miletich, Elisa Furfaro

Indian J Pediatr· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.
Maria N Gamaletsou, Blandine Rammaert, Marimelle A Bueno, Brad Moriyama, Nikolaos V Sipsas, Roberta Prinapori

J Infect· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapy.
Antonio Di Biagio, Andrea Parisini, Bianca Bruzzone, Roberta Prinapori, Marinella Lauriola

HIV Clin Trials· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women?
Roberta Prinapori, Rffaella Rosso, Antonio Di Biagio, Laura Nicolini, Daniele Roberto Giacobbe

New Microbiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: case report and literature review.
Laura De Hoffer, Antonio Di Biagio, Bianca Bruzzone, Laura Sticchi, Roberta Prinapori

J Chemother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
Roberta Prinapori, Julie Guinaud, Antoine Khalil, Herve Lecuyer, Dominique Gendrel

Am J Infect Control· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
Antonio Di Biagio, Roberta Prinapori, Diana Giannarelli, Franco Maggiolo, Simona Di Giambenedetto

J Antimicrob Chemother· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci.
Malgorzata Mikulska, Valerio Del Bono, Anna Maria Raiola, Alessio Signori, Roberta Prinapori

Clin Infect Dis· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis